Literature DB >> 18661152

2008 update of the guideline: early detection of breast cancer in Germany.

Ute-Susann Albert1, Helmut Altland, Volker Duda, Jutta Engel, Max Geraedts, Syvia Heywang-Köbrunner, Dieter Hölzel, Eva Kalbheim, Michael Koller, Klaus König, Rolf Kreienberg, Thorsten Kühn, Annette Lebeau, Irmgard Nass-Griegoleit, Werner Schlake, Rita Schmutzler, Ingrid Schreer, Hilde Schulte, Rüdiger Schulz-Wendtland, Uwe Wagner, Ina Kopp.   

Abstract

INTRODUCTION: The goal of the 2008 updated guideline: early detection of breast cancer in Germany is to support physicians as well as healthy and affected women in the decision-making process involved in the diagnostic chain for the early detection of breast cancer by providing them with evidence- and consensus-based recommendations. The updated guideline replaces the guideline issued in 2003.
MATERIALS AND METHODS: The guideline forms the basis for developing an effective and efficient national early breast cancer detection program that meets the standards set by the Council of Europe and WHO for cancer control programs. The guideline presents the current, evidence- and consensus-based state of scientific knowledge in a multidisciplinary approach for the entire diagnostic chain, consisting of history taking and risk consultation, information on health behavior, clinical breast examination, diagnostic imaging, image-guided percutaneous tissue-acquisition techniques, open surgical excisional biopsy and pathomorphological tissue evaluation. The guideline recommends a set of quality indicators to assure resource availability, performance quality and outcomes enhancing total quality management for early breast cancer diagnosis.
CONCLUSION: Currently, early detection of breast cancer offers the most promising possibility to optimize the diagnosis and treatment of breast cancer and, as a result, reduce breast cancer mortality and improve health related quality of life in women.

Entities:  

Mesh:

Year:  2008        PMID: 18661152     DOI: 10.1007/s00432-008-0450-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  20 in total

1.  American Cancer Society guidelines for breast cancer screening: update 2003.

Authors:  Robert A Smith; Debbie Saslow; Kimberly Andrews Sawyer; Wylie Burke; Mary E Costanza; W Phil Evans; Roger S Foster; Edward Hendrick; Harmon J Eyre; Steven Sener
Journal:  CA Cancer J Clin       Date:  2003 May-Jun       Impact factor: 508.702

2.  [BI-RADS-analogue DEGUM criteria for findings in breast ultrasound--consensus of the DEGUM Committee on Breast Ultrasound].

Authors:  H Madjar; R Ohlinger; A Mundinger; D Watermann; J P Frenz; W Bader; R Schulz-Wendtland; F Degenhardt
Journal:  Ultraschall Med       Date:  2006-08       Impact factor: 6.548

3.  Breast cancer in limited-resource countries: early detection and access to care.

Authors:  Robert A Smith; Maira Caleffi; Ute-Susann Albert; Tony H H Chen; Stephen W Duffy; Dido Franceschi; Lennarth Nyström
Journal:  Breast J       Date:  2006 Jan-Feb       Impact factor: 2.431

4.  [Not Available].

Authors:  I Kopp; A Encke; W Lorenz
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2002-03       Impact factor: 1.513

5.  Prognostic classification of breast ductal carcinoma-in-situ.

Authors:  M J Silverstein; D N Poller; J R Waisman; W J Colburn; A Barth; E D Gierson; B Lewinsky; P Gamagami; D J Slamon
Journal:  Lancet       Date:  1995-05-06       Impact factor: 79.321

6.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Authors:  J M Harvey; G M Clark; C K Osborne; D C Allred
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

7.  Accuracy of sonographically guided 14-gauge core-needle biopsy: results of 715 consecutive breast biopsies with at least two-year follow-up of benign lesions.

Authors:  Pavel Crystal; Michael Koretz; Semyon Shcharynsky; Victoria Makarov; Selwyn Strano
Journal:  J Clin Ultrasound       Date:  2005-02       Impact factor: 0.910

8.  Estimates of the cancer incidence and mortality in Europe in 2006.

Authors:  J Ferlay; P Autier; M Boniol; M Heanue; M Colombet; P Boyle
Journal:  Ann Oncol       Date:  2007-02-07       Impact factor: 32.976

9.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.

Authors:  C W Elston; I O Ellis
Journal:  Histopathology       Date:  1991-11       Impact factor: 5.087

Review 10.  Short version of the Guideline: Early Detection of Breast Cancer in Germany. An evidence-, consensus-, and outcome-based guideline according to the German Association of the Scientific Medical Societies (AWMF) and the German Agency for Quality in Medicine (AeZQ).

Authors:  U-S Albert; K-D Schulz
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-18       Impact factor: 4.553

View more
  13 in total

1.  Breast Centers in Germany.

Authors:  Ute-Susann Albert; Uwe Wagner; Matthias Kalder
Journal:  Breast Care (Basel)       Date:  2009-08-14       Impact factor: 2.860

2.  B3 Lesions: Radiological Assessment and Multi-Disciplinary Aspects.

Authors:  Sylvia H Heywang-Köbrunner; Jörg Nährig; Astrid Hacker; Stefan Sedlacek; Heinz Höfler
Journal:  Breast Care (Basel)       Date:  2010-08-23       Impact factor: 2.860

3.  Digital mammography screening: how many breast cancers are additionally detected by bilateral ultrasound examination during assessment?

Authors:  Stefanie Weigel; Cornelis Biesheuvel; Shoma Berkemeyer; Harald Kugel; Walter Heindel
Journal:  Eur Radiol       Date:  2012-10-07       Impact factor: 5.315

4.  Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany.

Authors:  Dorothea Gadzicki; D Gareth Evans; Hilary Harris; Claire Julian-Reynier; Irmgard Nippert; Jörg Schmidtke; Aad Tibben; Christi J van Asperen; Brigitte Schlegelberger
Journal:  J Community Genet       Date:  2011-03-02

5.  Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills.

Authors:  J Graf; E Simoes; K Wißlicen; L Rava; C B Walter; A Hartkopf; L Keilmann; A Taran; S Wallwiener; P Fasching; S Y Brucker; M Wallwiener
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-05       Impact factor: 2.915

6.  Optimization of the energy for Breast monochromatic absorption X-ray Computed Tomography.

Authors:  Pasquale Delogu; Vittorio Di Trapani; Luca Brombal; Giovanni Mettivier; Angelo Taibi; Piernicola Oliva
Journal:  Sci Rep       Date:  2019-09-11       Impact factor: 4.379

Review 7.  Differentiating vacuum-assisted breast biopsy from core needle biopsy: Is it necessary?

Authors:  Satoko Nakano; Yoshimi Imawari; Akemi Mibu; Masahiko Otsuka; Toshinori Oinuma
Journal:  Br J Radiol       Date:  2018-07-20       Impact factor: 3.039

8.  Adopting Guidelines into Clinical Practice: Implementation of Trastuzumab in the Adjuvant Treatment of Breast Cancer in Lower Saxony, Germany, in 2007.

Authors:  Clemens Liebrich; Günter Unger; Birgit Dlugosch; Stefan Hofmann; Karl U Petry
Journal:  Breast Care (Basel)       Date:  2011-01-31       Impact factor: 2.860

Review 9.  A literature review on the imaging methods for breast cancer.

Authors:  Reza Gerami; Saeid Sadeghi Joni; Negin Akhondi; Ali Etemadi; Mahnaz Fosouli; Aynaz Foroughi Eghbal; Zobin Souri
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-06-15

Review 10.  Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review.

Authors:  Monika Nothacker; Volker Duda; Markus Hahn; Mathias Warm; Friedrich Degenhardt; Helmut Madjar; Susanne Weinbrenner; Ute-Susann Albert
Journal:  BMC Cancer       Date:  2009-09-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.